Varinder Jeet

1.7k total citations · 1 hit paper
24 papers, 1.3k citations indexed

About

Varinder Jeet is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Varinder Jeet has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Varinder Jeet's work include Prostate Cancer Treatment and Research (7 papers), MicroRNA in disease regulation (6 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Varinder Jeet is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), MicroRNA in disease regulation (6 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Varinder Jeet collaborates with scholars based in Australia, Canada and India. Varinder Jeet's co-authors include Andrew J. Kassianos, Kylie McDonald, Kristen J. Radford, Derek N.J. Hart, Catherine E. Angel, Sarah L. Jongbloed, Georgina J. Clark, Xinsheng Ju, Annelie Vulink and P. Rod Dunbar and has published in prestigious journals such as The Journal of Experimental Medicine, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Varinder Jeet

23 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens

2010 796 citations Sarah L. Jongbloed, Andrew J. Kassianos et al. The Journal of Experimental Medicine profile →

Peers

Countries citing papers authored by Varinder Jeet

Since Specialization

Citations

This map shows the geographic impact of Varinder Jeet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Varinder Jeet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Varinder Jeet more than expected).

Fields of papers citing papers by Varinder Jeet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Varinder Jeet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Varinder Jeet. The network helps show where Varinder Jeet may publish in the future.

Co-authorship network of co-authors of Varinder Jeet

This figure shows the co-authorship network connecting the top 25 collaborators of Varinder Jeet. A scholar is included among the top collaborators of Varinder Jeet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Varinder Jeet. Varinder Jeet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lactoferrin-encapsulated dichloroacetophenone (DAP) nanoparticles enhance drug delivery and anti-tumor efficacy in prostate cancer 2025 ·Cancer Letters ·(unknown), Varinder Jeet, Jennifer H. Gunter, (unknown), (unknown), Judith A. Clements, Srilakshmi Srinivasan, Amirali Popat, Jyotsna Batra	3
2	Unravelling the Association Between Uncertainties in Model-based Economic Analysis and Funding Recommendations of Medicines in Australia 2024 ·PharmacoEconomics ·(unknown), Martin Hoyle, Varinder Jeet, Yuanyuan Gu, Kompal Sinha, Bonny Parkinson	0
3	Barriers and facilitators to implementing priority setting and resource allocation tools in hospital decisions: A systematic review 2023 ·Social Science & Medicine ·(unknown), Varinder Jeet, (unknown), (unknown), Yuanyuan Gu, Henry Cutler	9
4	Histopathologically Validated Diagnostic Accuracy of PSMA-PET/CT in the Primary and Secondary Staging of Prostate Cancer and the Impact of PSMA-PET/CT on Clinical Management: A Systematic Review and Meta-analysis 2023 ·Seminars in Nuclear Medicine ·Varinder Jeet, Bonny Parkinson, (unknown), Rajan Sharma, Martin Hoyle	18
5	Patient Preferences in Targeted Pharmacotherapy for Cancers: A Systematic Review of Discrete Choice Experiments 2022 ·PharmacoEconomics ·Shan Jiang, (unknown), Yuanyuan Gu, Varinder Jeet, Ping Liu, Shunping Li	14
6	Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia 2022 ·PharmacoEconomics ·(unknown), Varinder Jeet, Rajan Sharma, Martin Hoyle, Bonny Parkinson	18
7	Using Australian panel data to account for unobserved factors in measuring inequities for different channels of healthcare utilization 2021 ·The European Journal of Health Economics ·Jonas Fooken, Varinder Jeet	1
8	Allele-Specific MicroRNA-Mediated Regulation of a Glycolysis Gatekeeper PDK1 in Cancer Metabolism 2021 ·Cancers ·(unknown), Varinder Jeet, Jennifer H. Gunter, Judith A. Clements, Jyotsna Batra	13
9	Targeted beta therapy of prostate cancer with 177Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1) 2020 ·EJNMMI Research ·(unknown), Brian Wan-Chi Tse, Nicholas L. Fletcher, Zachary H. Houston, Maria E. Lund, (unknown), (unknown), Kamil A. Sokolowski, Varinder Jeet, Kristofer J. Thurecht, Douglas Houghton Campbell, Bradley J. Walsh, Colleen C. Nelson, Pamela J. Russell	19
10	Interleukin (IL)-22 from IL-20 Subfamily of Cytokines Induces Colonic Epithelial Cell Proliferation Predominantly through ERK1/2 Pathway 2019 ·International Journal of Molecular Sciences ·Md. Moniruzzaman, Ran Wang, Varinder Jeet, Michael A. McGuckin, Sumaira Z. Hasnain	37
11	A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate Cancer 2018 ·Scientific Reports ·(unknown), Varinder Jeet, Leire Moya, Luke A. Selth, Suzanne K. Chambers, (unknown), Trina Yeadon, Philippa T. K. Saunders, Anne Eckert, Peter Heathcote, Geoffrey A. Wood, (unknown), Hemamali Samaratunga, Anne T. Collins, M. Turner, Kathleen F. Kerr, Judith A. Clements, Jyotsna Batra	70
12	Comprehensive profiling of androgen signalling and energy and lipid metabolism highlights heterogeneity of prostate cancer cell lines 2016 ·Martin C. Sadowski, Stephen J. McPherson, Anja Rockstroh, Carolina Soekmadji, (unknown), Jennifer H. Gunter, Varinder Jeet, Colleen C. Nelson	1
13	More than a biomarker: exploring the role of glypican-1 as a new therapeutic target for prostate cancer 2016 ·QUT ePrints (Queensland University of Technology) ·Varinder Jeet, (unknown), Douglas Houghton Campbell, Bradley J. Walsh, Pamela J. Russell, Colleen C. Nelson	1
14	Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer 2015 ·Molecular and Cellular Endocrinology ·(unknown), Sean McGrath, Ryan Demeter, Vincent Magrini, Varinder Jeet, Anja Rockstroh, Stephen J. McPherson, John Lai, Nenad Bartoniček, Jiyuan An, Jyotsna Batra, Marcel E. Dinger, Melanie Lehman, Elizabeth D. Williams, Colleen C. Nelson	16
15	Differential uptake and cross‐presentation of soluble and necrotic cell antigen by human DC subsets 2015 ·European Journal of Immunology ·(unknown), Kirsteen M. Tullett, Yoke Seng Lee, Adi Idris, (unknown), Kylie McDonald, Andrew J. Kassianos, Ingrid Leal Rojas, Varinder Jeet, Mireille H. Lahoud, Kristen J. Radford	55
16	Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells 2014 ·Endocrine Related Cancer ·Varinder Jeet, (unknown), Margot Lehman, Brett G. Hollier, Colleen C. Nelson	21
17	Targeting Aurora Kinases: A Novel Approach to Curb the Growth & Chemoresistance of Androgen Refractory Prostate Cancer 2012 ·Current Cancer Drug Targets ·Varinder Jeet, Pamela J. Russell, Nirupama D. Verma, Aparajita Khatri	5
18	Modeling prostate cancer: a perspective on transgenic mouse models 2010 ·Cancer and Metastasis Reviews ·Varinder Jeet, Pamela J. Russell, Aparajita Khatri	29
19	Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens breakdown → 2010 ·The Journal of Experimental Medicine ·Sarah L. Jongbloed, Andrew J. Kassianos, Kylie McDonald, Georgina J. Clark, Xinsheng Ju, Catherine E. Angel, Chun‐Jen J. Chen, P. Rod Dunbar, Robert Wadley, Varinder Jeet, Annelie Vulink, Derek N.J. Hart, Kristen J. Radford	796
20	Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer 2008 ·The Prostate ·Varinder Jeet, Kim Ow, (unknown), (unknown), Pamela J. Russell, Aparajita Khatri	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact